ArticleCureus2025
Gastric Adenocarcinoma With Enteroblastic Differentiation and Coexisting Well-Differentiated Tubular Adenocarcinoma: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A 92-year-old male was referred to our hospital owing to progressive anemia and a positive fecal occult blood test. Upper gastrointestinal endoscopy revealed an advanced gastric carcinoma on the posterior wall of the lower gastric body, which was diagnosed as tubular adenocarcinoma by biopsy. The patient underwent an open distal gastrectomy, and the operative specimen showed a 45-mm-sized type 3 lesion on the posterior wall of the lower gastric body and a 35-mm-sized type 0-IIa tumor on the oral side of the type 3 lesion. Histopathological examination revealed that the type 3 lesion contained cells with pale sporangia, and immunohistochemistry was positive for SALL4, α-fetoprotein, and Glypican-3, leading to a diagnosis of gastric adenocarcinoma with enteroblastic differentiation (GACED). The type 0-IIa tumor was negative for these immunostainings and was identified as a well-differentiated tubular adenocarcinoma. There was no mixture of the two tumors except for the border area. Intraoperative peritoneal washing cytology was positive, and the stage was pStage IV. Owing to his advanced age, postoperative chemotherapy was not initiated. At three months postoperatively, lung and liver metastases were detected. We report a case of GACED with coexisting well-differentiated tubular adenocarcinoma.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.